undefined undefined
NaN.000
NaN.00%
Aclarion(ACON.US):2024年Q1财报实现营收1.011万美元,前值为2.547万美元;每股收益为-0.44美元,前值为-2.40美元。
今天 06:03
TRACON Pharmaceuticals, Inc. (TCON) has issued an announcement. David Lazar has...
05-13 20:13
Pliant Therapeutics, Inc. (NASDAQ:PLRX) posted a loss for its first quarter on ...
05-07 23:53
Aclarion, Inc. (ACON) has shared an announcement. Aclarion, Inc. has successful...
04-29 20:13
Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during...
04-27 00:31
Losers: Lithium Americas Corp (LAC) -24% on plans for 55M-share offering. NRX Pharmaceuticals (NRXP) -22% announces proposed underwritten public offering of common stock. Canaan (CAN) -22% files for $...
04-18 20:15
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
04-10 22:20
Gainers: Adial Pharmaceuticals (ADIL) +90%. BioSig Technologies (BSGM) +15%. iCoreConnect (ICCT) +16%. MSP Recovery (LIFW) +11%. Revolution Medicines (RVMD) +8%. Losers: DocGo (DCGO) -25%. PainReform ...
04-10 22:02
Shares of Tracon Pharmaceuticals (NASDAQ:TCON) dropped sharply on Wednesday after early data from the company’s pivotal ENVASARC Phase 2 trial for its cancer therapy envafolimab disappointed investors...
04-04 01:52
苏州2024年3月29日 /美通社/ -- 康宁杰瑞生物制药(股票代码:9966.HK)公布了截至2023年12月31日的2023年度全年业绩和近期业务进展。...
03-29 09:56